WorldQuant Millennium Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

WorldQuant Millennium Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-54,467	Closed	-$6.23M	–	363
2020 Q3	$6.23M	Sell	54,467 -120,321	-69%	-$13M	0.15%	194
2020 Q2	$19.6M	Sell	174,788 -20,317	-10%	-$2.16M	0.45%	66
2020 Q1	$17.5M	Sell	195,105 -266,614	-58%	-$26.2M	0.43%	74
2019 Q4	$49.9M	Sell	461,719 -42,795	-8%	-$4.58M	0.96%	17
2019 Q3	$49.4M	Buy	504,514 +409,180	+429%	+$46.1M	0.96%	23
2019 Q2	$12.5M	Buy	+95,334	New	+$12.3M	0.24%	135

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

WorldQuant Millennium Advisors's ALXN Position: Q4 2020 in Review

WorldQuant Millennium Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 54,467 shares — an estimated $6.23M sold.

WorldQuant Millennium Advisors first reported a position in ALXN in Q2 2019 and held it in 6 quarters. The position peaked at $49.9M in Q4 2019. 824 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

WorldQuant Millennium Advisors reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
WorldQuant Millennium Advisors sold 54,467 Alexion Pharmaceuticals shares in Q4 2020, an estimated $6.23M.
WorldQuant Millennium Advisors first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 6 quarters.
WorldQuant Millennium Advisors's Alexion Pharmaceuticals position peaked at $49.9M in Q4 2019.
824 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on WorldQuant Millennium Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.